Skip to main content
Erschienen in: Current Neurology and Neuroscience Reports 3/2011

01.06.2011

Adult Primary Intradural Spinal Cord Tumors: A Review

verfasst von: Marc C. Chamberlain, Trent L. Tredway

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Primary spinal cord tumors constitute 2% to 4% of all central nervous system neoplasms and are characterized based on their location as intramedullary, intradural extramedullary, and extradural. A contemporary literature review of primary intradural spinal cord tumors was performed. Among intramedullary tumors, ependymomas are more common and often can be surgically resected. However, astrocytomas infiltrate the spinal cord and complete resection is rare. Intradural extramedullary tumors include schwannomas, neurofibromas, and meningiomas and are usually amenable to surgical resection. Radiotherapy is reserved for malignant variants and recurrent gliomas, whereas chemotherapy is administered for recurrent primary spinal cord tumors without surgical or radiotherapy options. Early recognition of the signs and symptoms related to primary spinal cord tumors facilitates timely discovery, treatment, potentially minimizes neurologic morbidity, and may improve outcome. Treatment consists of surgical resection, and predictors of outcome include preoperative functional status, histologic grade of tumor, and extent of surgical resection.
Literatur
1.
Zurück zum Zitat • Campello C, Le Floch A, Parker F, et al. Neuroepithelial intramedullary spinal cord tumors in adults: Study of 70 cases, in American Academy of Neurology Annual Meeting. 2009: Seattle, WA. This is a useful survey in a comparatively large and contemporary series of adults with spinal cord tumors. • Campello C, Le Floch A, Parker F, et al. Neuroepithelial intramedullary spinal cord tumors in adults: Study of 70 cases, in American Academy of Neurology Annual Meeting. 2009: Seattle, WA. This is a useful survey in a comparatively large and contemporary series of adults with spinal cord tumors.
2.
Zurück zum Zitat Elsberg CA. Some aspects of the diagnosis and surgical treatment of tumors of the spinal cord: With a study of the end results in a series of 119 operations. Ann Surg. 1925;81:1057–73.PubMedCrossRef Elsberg CA. Some aspects of the diagnosis and surgical treatment of tumors of the spinal cord: With a study of the end results in a series of 119 operations. Ann Surg. 1925;81:1057–73.PubMedCrossRef
3.
Zurück zum Zitat Parsa AT, Chi JH, Acosta Jr FL, et al. Intramedullary spinal cord tumors: Molecular insights and surgical innovation. Clin Neurosurg. 2005;52:76–84.PubMed Parsa AT, Chi JH, Acosta Jr FL, et al. Intramedullary spinal cord tumors: Molecular insights and surgical innovation. Clin Neurosurg. 2005;52:76–84.PubMed
4.
Zurück zum Zitat Lonser RR, Weil RJ, Wanebo JE, et al. Surgical management of spinal cord hemangioblastomas in patients with von hippel-lindau disease. J Neurosurg. 2003;98:106–16.PubMedCrossRef Lonser RR, Weil RJ, Wanebo JE, et al. Surgical management of spinal cord hemangioblastomas in patients with von hippel-lindau disease. J Neurosurg. 2003;98:106–16.PubMedCrossRef
5.
Zurück zum Zitat Kalayci M, Cagavi F, Gul S, et al. Intramedullary spinal cord metastases: Diagnosis and treatment - an illustrated review. Acta Neurochir (Wien). 2004;146:1347–54. discussion 1354.CrossRef Kalayci M, Cagavi F, Gul S, et al. Intramedullary spinal cord metastases: Diagnosis and treatment - an illustrated review. Acta Neurochir (Wien). 2004;146:1347–54. discussion 1354.CrossRef
6.
Zurück zum Zitat Raco A, Esposito V, Lenzi J, et al. Long-term follow-up of intramedullary spinal cord tumors: A series of 202 cases. Neurosurgery. 2005;56:972–81. discussion 972-81.PubMed Raco A, Esposito V, Lenzi J, et al. Long-term follow-up of intramedullary spinal cord tumors: A series of 202 cases. Neurosurgery. 2005;56:972–81. discussion 972-81.PubMed
7.
Zurück zum Zitat • Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: Current classification and mri features. Neuroradiology. 2008;50:301–14. This paper presents a cogent radiographic description of anatomic localization of spinal cord tumors. PubMedCrossRef • Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: Current classification and mri features. Neuroradiology. 2008;50:301–14. This paper presents a cogent radiographic description of anatomic localization of spinal cord tumors. PubMedCrossRef
8.
Zurück zum Zitat Jallo GI, Freed D, Epstein FJ. Spinal cord gangliogliomas: A review of 56 patients. J Neurooncol. 2004;68:71–7.PubMedCrossRef Jallo GI, Freed D, Epstein FJ. Spinal cord gangliogliomas: A review of 56 patients. J Neurooncol. 2004;68:71–7.PubMedCrossRef
9.
Zurück zum Zitat McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72:523–32.PubMedCrossRef McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurg. 1990;72:523–32.PubMedCrossRef
10.
Zurück zum Zitat Cooper PR, Epstein F. Radical resection of intramedullary spinal cord tumors in adults. Recent experience in 29 patients. J Neurosurg. 1985;63:492–9.PubMedCrossRef Cooper PR, Epstein F. Radical resection of intramedullary spinal cord tumors in adults. Recent experience in 29 patients. J Neurosurg. 1985;63:492–9.PubMedCrossRef
11.
Zurück zum Zitat Quinones-Hinojosa A, Gulati M, Lyon R, et al. Spinal cord mapping as an adjunct for resection of intramedullary tumors: Surgical technique with case illustrations. Neurosurgery. 2002;51:1199–206. discussion 1206-7.PubMedCrossRef Quinones-Hinojosa A, Gulati M, Lyon R, et al. Spinal cord mapping as an adjunct for resection of intramedullary tumors: Surgical technique with case illustrations. Neurosurgery. 2002;51:1199–206. discussion 1206-7.PubMedCrossRef
12.
Zurück zum Zitat Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol. 2000;47:231–8.PubMedCrossRef Isaacson SR. Radiation therapy and the management of intramedullary spinal cord tumors. J Neurooncol. 2000;47:231–8.PubMedCrossRef
13.
Zurück zum Zitat Linstadt DE, Wara WM, Leibel SA, et al. Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys. 1989;16:1397–403.PubMedCrossRef Linstadt DE, Wara WM, Leibel SA, et al. Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys. 1989;16:1397–403.PubMedCrossRef
14.
Zurück zum Zitat Gomez DR, Missett BT, Wara WM, et al. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol. 2005;7:254–9.PubMedCrossRef Gomez DR, Missett BT, Wara WM, et al. High failure rate in spinal ependymomas with long-term follow-up. Neuro Oncol. 2005;7:254–9.PubMedCrossRef
15.
Zurück zum Zitat Chamberlain MC. Etoposide for recurrent spinal cord ependymoma. Neurology. 2002;58:1310–1.PubMed Chamberlain MC. Etoposide for recurrent spinal cord ependymoma. Neurology. 2002;58:1310–1.PubMed
16.
Zurück zum Zitat • Chamberlain MC, Johnston SK. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer. 2009;115:4775–82. This is a case series of patients with recurrent ependymomas having failed prior platinum-based chemotherapy treated with TMZ to limited effect. PubMedCrossRef • Chamberlain MC, Johnston SK. Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma. Cancer. 2009;115:4775–82. This is a case series of patients with recurrent ependymomas having failed prior platinum-based chemotherapy treated with TMZ to limited effect. PubMedCrossRef
17.
Zurück zum Zitat • Green RM, Cloughesy TF, Stupp R, et al. Bevacizumab for recurrent ependymoma. Neurology. 2009;73:1677–80. This is the first study to suggest angiogenic inhibition may be beneficial for ependymomas. PubMedCrossRef • Green RM, Cloughesy TF, Stupp R, et al. Bevacizumab for recurrent ependymoma. Neurology. 2009;73:1677–80. This is the first study to suggest angiogenic inhibition may be beneficial for ependymomas. PubMedCrossRef
18.
Zurück zum Zitat •• Fouladi M, Stewart CF, Blaney SM, et al. Phase 1 trial of lapatinib in children with refractory cns malignancies: a pediatric brain tumor consortium study. J Clin Oncol. 2010;28:4221–7. This is a provocative phase 2 trial in children suggesting Her2/neu inhibition with lapatinib may have activity in recurrent ependymoma. PubMedCrossRef •• Fouladi M, Stewart CF, Blaney SM, et al. Phase 1 trial of lapatinib in children with refractory cns malignancies: a pediatric brain tumor consortium study. J Clin Oncol. 2010;28:4221–7. This is a provocative phase 2 trial in children suggesting Her2/neu inhibition with lapatinib may have activity in recurrent ependymoma. PubMedCrossRef
19.
Zurück zum Zitat Rodrigues GB, Waldron JN, Wong CS, Laperriere NJ. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int J Radiat Oncol Biol Phys. 2000;48:837–42.PubMedCrossRef Rodrigues GB, Waldron JN, Wong CS, Laperriere NJ. A retrospective analysis of 52 cases of spinal cord glioma managed with radiation therapy. Int J Radiat Oncol Biol Phys. 2000;48:837–42.PubMedCrossRef
20.
Zurück zum Zitat • Minehan KJ, Brown PD, Scheithauer BW, et al. Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys. 2009;73:727–33. This is an overview of the management of spinal cord gliomas with particular emphasis on surgery and radiotherapy. PubMedCrossRef • Minehan KJ, Brown PD, Scheithauer BW, et al. Prognosis and treatment of spinal cord astrocytoma. Int J Radiat Oncol Biol Phys. 2009;73:727–33. This is an overview of the management of spinal cord gliomas with particular emphasis on surgery and radiotherapy. PubMedCrossRef
21.
Zurück zum Zitat Innocenzi G, Salvati M, Cervoni L, et al. Prognostic factors in intramedullary astrocytomas. Clin Neurol Neurosurg. 1997;99:1–5.PubMedCrossRef Innocenzi G, Salvati M, Cervoni L, et al. Prognostic factors in intramedullary astrocytomas. Clin Neurol Neurosurg. 1997;99:1–5.PubMedCrossRef
22.
Zurück zum Zitat • Ewelt C, Stummer W, Klink B, et al. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg. 2010;112:357–61. This is the first case describing the in vivo localization method of preoperative administration of 5-ALA to permit resection of a high-grade glioma of the spinal cord. PubMedCrossRef • Ewelt C, Stummer W, Klink B, et al. Cordectomy as final treatment option for diffuse intramedullary malignant glioma using 5-ALA fluorescence-guided resection. Clin Neurol Neurosurg. 2010;112:357–61. This is the first case describing the in vivo localization method of preoperative administration of 5-ALA to permit resection of a high-grade glioma of the spinal cord. PubMedCrossRef
23.
Zurück zum Zitat Abdel-Wahab M, Etuk B, Palermo J, et al. Spinal cord gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys. 2006;64:1060–71.PubMedCrossRef Abdel-Wahab M, Etuk B, Palermo J, et al. Spinal cord gliomas: a multi-institutional retrospective analysis. Int J Radiat Oncol Biol Phys. 2006;64:1060–71.PubMedCrossRef
24.
Zurück zum Zitat • Chamberlain MC. Temozolomide for recurrent low-grade spinal cord gliomas in adults. Cancer. 2008;113:1019–24. This is another small case series directed at the role of TMZ for recurrent low-grade spinal cord gliomas. PubMedCrossRef • Chamberlain MC. Temozolomide for recurrent low-grade spinal cord gliomas in adults. Cancer. 2008;113:1019–24. This is another small case series directed at the role of TMZ for recurrent low-grade spinal cord gliomas. PubMedCrossRef
25.
Zurück zum Zitat • Kaley T, Abrey LE. Temozolomide for spinal cord high-grade gliomas, in American Academy of Neurology 2009 Annual Meeting. 2009: Seattle WA. This is a case series of recurrent spinal cord glioblastoma treated with bevacizumab. • Kaley T, Abrey LE. Temozolomide for spinal cord high-grade gliomas, in American Academy of Neurology 2009 Annual Meeting. 2009: Seattle WA. This is a case series of recurrent spinal cord glioblastoma treated with bevacizumab.
26.
Zurück zum Zitat • Chamberlain MC, Johnston SK. Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab. J Neurooncol. 2010. doi:10.1007/s11060-010-0330-6. This is a case series of recurrent spinal cord glioblastoma treated with bevacizumab. • Chamberlain MC, Johnston SK. Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab. J Neurooncol. 2010. doi:10.​1007/​s11060-010-0330-6. This is a case series of recurrent spinal cord glioblastoma treated with bevacizumab.
27.
Zurück zum Zitat Lee DK, Choe WJ, Chung CK, Kim HJ. Spinal cord hemangioblastoma: Surgical strategy and clinical outcome. J Neurooncol. 2003;61:27–34.PubMedCrossRef Lee DK, Choe WJ, Chung CK, Kim HJ. Spinal cord hemangioblastoma: Surgical strategy and clinical outcome. J Neurooncol. 2003;61:27–34.PubMedCrossRef
28.
Zurück zum Zitat Eskridge JM, McAuliffe W, Harris B, et al. Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol. 1996;17:525–31.PubMed Eskridge JM, McAuliffe W, Harris B, et al. Preoperative endovascular embolization of craniospinal hemangioblastomas. AJNR Am J Neuroradiol. 1996;17:525–31.PubMed
29.
Zurück zum Zitat Ryu SI, Kim DH, Chang SD. Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus. 2003;15:E10.PubMedCrossRef Ryu SI, Kim DH, Chang SD. Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus. 2003;15:E10.PubMedCrossRef
30.
Zurück zum Zitat Schuch G, de Wit M, Holtje J, et al. Case 2. Hemangioblastomas: diagnosis of von hippel-lindau disease and antiangiogenic treatment with su5416. J Clin Oncol. 2005;23:3624–6.PubMedCrossRef Schuch G, de Wit M, Holtje J, et al. Case 2. Hemangioblastomas: diagnosis of von hippel-lindau disease and antiangiogenic treatment with su5416. J Clin Oncol. 2005;23:3624–6.PubMedCrossRef
31.
Zurück zum Zitat • Benesch M, Windelberg M, Sauseng W, et al. Compassionate use of bevacizumab (avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol. 2008;19:807–13. This discusses bevacizumab for recurent pediatric brain tumors and demonstrating limited utility. PubMedCrossRef • Benesch M, Windelberg M, Sauseng W, et al. Compassionate use of bevacizumab (avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol. 2008;19:807–13. This discusses bevacizumab for recurent pediatric brain tumors and demonstrating limited utility. PubMedCrossRef
32.
Zurück zum Zitat Patel U, Pinto RS, Miller DC, et al. Mr of spinal cord ganglioglioma. AJNR Am J Neuroradiol. 1998;19:879–87.PubMed Patel U, Pinto RS, Miller DC, et al. Mr of spinal cord ganglioglioma. AJNR Am J Neuroradiol. 1998;19:879–87.PubMed
33.
Zurück zum Zitat Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery. 1998;42:1038–43.PubMedCrossRef Rumana CS, Valadka AB. Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery. 1998;42:1038–43.PubMedCrossRef
34.
Zurück zum Zitat • Machiya T, Yoshita M, Iwasa K, Yamada M. Primary spinal intramedullary lymphoma mimicking ependymoma. Neurology. 2007;68:872. This is a case report of a primary CNS lymphoma originating in the spinal cord. PubMedCrossRef • Machiya T, Yoshita M, Iwasa K, Yamada M. Primary spinal intramedullary lymphoma mimicking ependymoma. Neurology. 2007;68:872. This is a case report of a primary CNS lymphoma originating in the spinal cord. PubMedCrossRef
35.
Zurück zum Zitat Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary cns lymphoma: the next step. J Clin Oncol. 2000;18:3144–50.PubMed Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary cns lymphoma: the next step. J Clin Oncol. 2000;18:3144–50.PubMed
36.
Zurück zum Zitat • Yang KY, Li SH, Lin JW, et al. Concurrent chemoradiotherapy for primary cervical spinal cord germinoma. J Clin Neurosci. 2009;16:115–8. This is a case report of a primary spinal cord germinoma treated with chemoradiotherapy. PubMedCrossRef • Yang KY, Li SH, Lin JW, et al. Concurrent chemoradiotherapy for primary cervical spinal cord germinoma. J Clin Neurosci. 2009;16:115–8. This is a case report of a primary spinal cord germinoma treated with chemoradiotherapy. PubMedCrossRef
37.
Zurück zum Zitat Farrokh D, Fransen P, Faverly D. Mr findings of a primary intramedullary malignant melanoma: case report and literature review. AJNR Am J Neuroradiol. 2001;22:1864–6.PubMed Farrokh D, Fransen P, Faverly D. Mr findings of a primary intramedullary malignant melanoma: case report and literature review. AJNR Am J Neuroradiol. 2001;22:1864–6.PubMed
38.
Zurück zum Zitat Jinnai T, Koyama T. Clinical characteristics of spinal nerve sheath tumors: analysis of 149 cases. Neurosurgery. 2005;56:510–5. discussion 510-5.PubMedCrossRef Jinnai T, Koyama T. Clinical characteristics of spinal nerve sheath tumors: analysis of 149 cases. Neurosurgery. 2005;56:510–5. discussion 510-5.PubMedCrossRef
39.
Zurück zum Zitat • Gerszten PC, Burton SA, Ozhasoglu C, et al. Radiosurgery for benign intradural spinal tumors. Neurosurgery. 2008;62:887–95. discussion 895-6. This paper discusses data supporting a selected role for stereotactic surgery in the treatment of extramedullary intradural spinal cord tumors.PubMedCrossRef • Gerszten PC, Burton SA, Ozhasoglu C, et al. Radiosurgery for benign intradural spinal tumors. Neurosurgery. 2008;62:887–95. discussion 895-6. This paper discusses data supporting a selected role for stereotactic surgery in the treatment of extramedullary intradural spinal cord tumors.PubMedCrossRef
40.
Zurück zum Zitat Tredway TL, Santiago P, Hrubes MR, et al. Minimally invasive resection of intradural-extramedullary spinal neoplasms. Neurosurgery. 2006;58:ONS52-8. discussion ONS52-8.CrossRef Tredway TL, Santiago P, Hrubes MR, et al. Minimally invasive resection of intradural-extramedullary spinal neoplasms. Neurosurgery. 2006;58:ONS52-8. discussion ONS52-8.CrossRef
41.
Zurück zum Zitat Evans DG, Birch JM, Ramsden RT, et al. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour prone syndromes. J Med Genet. 2006;43:289–94.PubMedCrossRef Evans DG, Birch JM, Ramsden RT, et al. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour prone syndromes. J Med Genet. 2006;43:289–94.PubMedCrossRef
42.
Zurück zum Zitat Gezen F, Kahraman S, Canakci Z, Beduk A. Review of 36 cases of spinal cord meningioma. Spine (Phila Pa 1976). 2000;25:727–31. Gezen F, Kahraman S, Canakci Z, Beduk A. Review of 36 cases of spinal cord meningioma. Spine (Phila Pa 1976). 2000;25:727–31.
43.
Zurück zum Zitat Peker S, Cerci A, Ozgen S, et al. Spinal meningiomas: evaluation of 41 patients. J Neurosurg Sci. 2005;49:7–11.PubMed Peker S, Cerci A, Ozgen S, et al. Spinal meningiomas: evaluation of 41 patients. J Neurosurg Sci. 2005;49:7–11.PubMed
44.
Zurück zum Zitat Solero CL, Fornari M, Giombini S, et al. Spinal meningiomas: review of 174 operated cases. Neurosurgery. 1989;25:153–60.PubMedCrossRef Solero CL, Fornari M, Giombini S, et al. Spinal meningiomas: review of 174 operated cases. Neurosurgery. 1989;25:153–60.PubMedCrossRef
45.
Zurück zum Zitat Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838–46.PubMedCrossRef Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurgery. 2001;49:838–46.PubMedCrossRef
46.
Zurück zum Zitat Chamberlain MC, Blumenthal DT. Intracranial meningiomas: diagnosis and treatment. Expert Rev Neurother. 2004;4:641–8.PubMedCrossRef Chamberlain MC, Blumenthal DT. Intracranial meningiomas: diagnosis and treatment. Expert Rev Neurother. 2004;4:641–8.PubMedCrossRef
47.
Zurück zum Zitat • Chamberlain MC, Glantz MJ. Interferon-alpha for recurrent world health organization grade 1 intracranial meningiomas. Cancer. 2008;113:2146–51. This is the largest series of adults with recurrent meningiomas treated with interferon-α. PubMedCrossRef • Chamberlain MC, Glantz MJ. Interferon-alpha for recurrent world health organization grade 1 intracranial meningiomas. Cancer. 2008;113:2146–51. This is the largest series of adults with recurrent meningiomas treated with interferon-α. PubMedCrossRef
48.
Zurück zum Zitat • DeBoer R, Chandler J, Gallot L, et al. A phase ii trial of ptk-787 (ptk/zk) in recurrent or progressive meningiomas, in American Society of Clinical Oncology Annual Meeting. 2008: Chicago IL. p. 2060. This is the first report of an angiogenic inhibitor in the treatment of recurrent meningioma. • DeBoer R, Chandler J, Gallot L, et al. A phase ii trial of ptk-787 (ptk/zk) in recurrent or progressive meningiomas, in American Society of Clinical Oncology Annual Meeting. 2008: Chicago IL. p. 2060. This is the first report of an angiogenic inhibitor in the treatment of recurrent meningioma.
49.
Zurück zum Zitat • Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology. 2007;69:969–73. This is the first case series suggesting activity for a somatostatin analogue in the treatment of recurrent meningioma. PubMedCrossRef • Chamberlain MC, Glantz MJ, Fadul CE. Recurrent meningioma: salvage therapy with long-acting somatostatin analogue. Neurology. 2007;69:969–73. This is the first case series suggesting activity for a somatostatin analogue in the treatment of recurrent meningioma. PubMedCrossRef
50.
Zurück zum Zitat •• Milano MT, Johnson MD, Sul J, et al. Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. J Neurooncol. 2010;98:83–92. This is a review of the multi-institutional cancer registry focusing on spinal cord tumors. PubMedCrossRef •• Milano MT, Johnson MD, Sul J, et al. Primary spinal cord glioma: a surveillance, epidemiology, and end results database study. J Neurooncol. 2010;98:83–92. This is a review of the multi-institutional cancer registry focusing on spinal cord tumors. PubMedCrossRef
Metadaten
Titel
Adult Primary Intradural Spinal Cord Tumors: A Review
verfasst von
Marc C. Chamberlain
Trent L. Tredway
Publikationsdatum
01.06.2011
Verlag
Current Science Inc.
Erschienen in
Current Neurology and Neuroscience Reports / Ausgabe 3/2011
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-011-0190-2

Weitere Artikel der Ausgabe 3/2011

Current Neurology and Neuroscience Reports 3/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.